In this context, serum concentration of brain proteins such as the neuron-derived enzyme neuron-specific enolase (NSE), which is released after stroke [12] and cardiac arrest [13], has been assessed as a method of predicting secondary brain injury. The gene discussed is ENO2; the disease is cardiac arrest.